Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    20817281 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW - ACS)
Condition: Acute Coronary Syndrome
Intervention: Drug: Aspirin
2 Recruiting Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Cilostazol
3 Completed
Has Results
Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS
Conditions: Acute Coronary Disease;   Angina Unstable
Interventions: Drug: Clopidogrel;   Drug: acetylsalicyclic acid (ASA)

Indicates status has not been verified in more than two years